Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)

Bullboard - Stock Discussion Forum Valeo Pharma Inc VPHIF

Healthcare

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler,... see more

Add To Watchlist

Bullboard (GREY:VPHIF)

View:

Post by kooter33on Jul 06, 2021 5:32pm

Interview with Steve Saviuk CEO on Agoracom

https://www.youtube.com/watch?v=KnQSXm3v2g8&t=31s

176

Comment by Royal10on Jun 30, 2021 10:16am

RE:RE:RE:this company is NO-BRAINER

Strong growth now and in next quarters, according to Q2, 2021 financial results. Price is still pressured by brokers selling their overallotment via ANONYMOUS. I bought mores shares this morning ...more

213

Discussion

NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets

posted Nov 14, 2024 9:00am by NurExone Biologic Inc.

“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more

Comment by Kingofstockston Jun 30, 2021 9:25am

RE:RE:this company is NO-BRAINER

No such thing as weak growth, growth is great, the money making products where barely counted in that quarter so sit back relax and load up if possible as things from here are going to be great.

149

Discussion

Comment by Finallytherockon Jun 29, 2021 8:56pm

RE:this company is NO-BRAINER

The revenues continue to be unimpressive. Growth is very weak.

137

Discussion

Comment by Marketwatchmanon Jun 25, 2021 9:06am

RE:this company is NO-BRAINER

At this price, i think is time to buy. Q2 is near....

160

Discussion

Post by kooter33on Jun 24, 2021 11:53am

this company is NO-BRAINER

it tremendously " undervalued". Speculators/Investors will see this shortly when Q2 report comes out on the Jjn e 29th after close, Q2 call, and the closing of the "$10 M bought ...more

295

Discussion

Post by kijijion Jun 22, 2021 9:00am

VPH Launches Enerzair® Breezhaler® and Atectura® Breezhaler®

Product shipments have commenced across Canada National respiratory sales force recruitment well advanced, field deployment on-going Private and public reimbursement coverage progressing Nelly ...more

149

Comment by kooter33on Jun 18, 2021 3:26pm

RE:Summer slow down

Agreed, get this damn bought deal closed and the release of the Q2 report, then the Montreal Heart Institute report sometime in July, this stock should be on track to hit Paradigm's target of $ 3 ...more

147

Discussion

Post by JACKTHEBEAR2on Jun 11, 2021 5:27pm

Summer slow down

I think we are witnessing the summer slow down sell all specs period and only a nice revenue boost release will get us back on track. It will come.

201

Discussion

Post by kijijion Jun 08, 2021 5:33pm

Valeo Pharma arranges $10M bought deal offering $1 per unit

Valeo Pharma Inc. has entered into an agreement with Research Capital Corp. as the lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters, pursuant to which ...more

239

Comment by kooter33on Jun 07, 2021 4:28pm

RE:1.20

Valeo needs institutional support, they have 2 analysts reports which show that the next 12 months VPH should be at $3.30 to $3.50. Right now all we are seeing is a "rinse and repeat" ...more

169

Discussion

Post by JACKTHEBEAR2on Jun 03, 2021 8:54pm

1.20

When we crack 1.20 things should work towards 1.40 and a new range without news will take place. Bottom line this is worth alot more then current levels.The science will bare fruit soon.

203

Discussion

Post by FluidDrummeron May 26, 2021 4:40pm

Projecting record revenues

https://finance.yahoo.com/news/valeo-pharma-projecting-record-revenues-110000946.html

150

Comment by Kingofstockston May 12, 2021 5:06pm

RE:Paradigm Capital: new coverage with price target 3.50 CAD

That's great to read, this is a great price to really load up shares and hold. Glta

157

Discussion

Post by LaurinDEon May 12, 2021 3:36am

Paradigm Capital: new coverage with price target 3.50 CAD

Paradigm Capital: target 3.50 CAD for details see here: https://cdn-ceo-ca.s3.amazonaws.com/1g9l76k-VPH%202021%2005%2011_Initiating%20Coverage.pdf

290

Discussion

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Bullboard - Stock Discussion Forum Valeo Pharma Inc VPHIF

Bullboard (GREY:VPHIF)

Interview with Steve Saviuk CEO on Agoracom

RE:RE:RE:this company is NO-BRAINER

NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets

RE:RE:this company is NO-BRAINER

RE:this company is NO-BRAINER

RE:this company is NO-BRAINER

this company is NO-BRAINER

VPH Launches Enerzair® Breezhaler® and Atectura® Breezhaler®

RE:Summer slow down

Summer slow down

Valeo Pharma arranges $10M bought deal offering $1 per unit

RE:1.20

1.20

Projecting record revenues

RE:Paradigm Capital: new coverage with price target 3.50 CAD

Paradigm Capital: new coverage with price target 3.50 CAD

Featured News Links

Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.

Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023

Gold, growth and sustainability in focus for this resource company

Star Diamond Corporation Announces Third Quarter 2024 Results

Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits

Explained: The Psychology of Options Trading with Practical Tips

Meet the Top 5 Best Online Brokerages in Canada

Major Funding Secured! Company Closes First Round of Private Placement

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum Valeo Pharma Inc VPHIF

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (GREY:VPHIF)

Featured News Links